X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.35
Delayed Data
As of 3:03pm ET
 +0.05 / +2.17%
Today’s Change
1.55
Today|||52-Week Range
5.04
+18.69%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.30
Today’s open2.30
Day’s range2.29 - 2.50
Volume37,700
Average volume (3 months)14,439
Market cap$27.4M
Dividend yield--
Data as of 3:03pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-83.83%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+153.36%
P/E ratio--
Price/Sales13.65
Price/Book4.16

Competitors

 Today’s
change
Today’s
% change
NUINNutrastar Internatio...-0.02-2.67%
TPITianyin Pharmaceutic...+0.01+2.00%
--Axim Biotechnologies...0.000.00%
EVOKEvoke Pharma Inc+0.05+0.71%
Data as of 3:34pm ET, 04/01/2015

Financials

Last reporting dateSeptember 8, 2008
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$2.4M
Annual profit (last year)-$2.5M
Net profit margin-104.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Herzliya, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account